Edgewise Therapeutics, Inc.
Edgewise Therapeutics, Inc. (EWTX) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
ewtx · stock forecast · 10 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 10 Wall Street analysts in the past 3 months
Buy
10 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$66.00
Consensus
$47.57
+37.1% upside
Low
$25.00
Median: $48 · Last Close: $34.70
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$47.57
37.1% upside
High Target
$66
90.2%
Low Target
$25
-28.0%
Current Price
$34.70
as of today
Based on analyst price targets, the EWTX stock price prediction for the next 12 months ranges from $25 to $66. The consensus EWTX price forecast of $47.57 implies 37.1% upside from the current price of $34.70.
Short-Term Price Prediction
BullAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $36.41 | ↑ 4.92% |
1-day model range: $36.02–$36.79. Peak: $36.79 (+4.92%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $32 | -8.4% |
| 2028 | $30 | -13.0% |
| 2029 | $29 | -15.6% |
| 2030 | $29 | -17.1% |
| 2031 | — | -18.0% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · EWTX · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-06-02 | Wedbush | Maintains | Outperform→Outperform |
| 2026-06-02 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-06-02 | RBC Capital | Maintains | Outperform→Outperform |
| 2026-03-17 | Wedbush | Maintains | Outperform→Outperform |
| 2026-03-17 | JP Morgan | Maintains | Overweight→Overweight |
| 2026-02-27 | Evercore ISI Group | Maintains | Outperform→Outperform |
| 2025-11-14 | JP Morgan | Maintains | Overweight→Overweight |
| 2025-11-07 | Wedbush | Maintains | Outperform→Outperform |
| 2025-11-07 | RBC Capital | Maintains | Outperform→Outperform |
| 2025-08-19 | JP Morgan | Maintains | Overweight→Overweight |
Wall Street analysts have recently issued updated ratings on Edgewise Therapeutics, Inc. (EWTX) stock. Of the recent 55 rating actions, 0 were upgrades and 2 were downgrades. 10 analysts currently cover EWTX.
Analyst Recommendation Trends
EWTX analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 3 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$2M
↓ 97.6% YoY
Revenue Next Year
$30M
↑ 1208.2% YoY
EPS This Year
$-1.94
EPS Next Year
$-1.85
↓ 4.4% YoY
EPS ForecastReported vs Estimated
Analysts forecast EWTX EPS of $-1.94 for the current fiscal year, based on estimates from 7 analysts. The EWTX revenue forecast is $2M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The EWTX stock forecast is supported by two independent data sources: analyst consensus ratings from 10 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus EWTX price target is $47.57 (+37.1% upside), with an analyst consensus of Buy.
The EWTX short-term stock prediction for tomorrow is $36.41 (+4.92%). The EWTX stock price prediction for 2027 estimates an average of $32. The EWTX stock prediction for 2030 projects a range of $25–$32.
Edgewise Therapeutics, Inc. trades on NASDAQ under the ticker EWTX. The EWTX stock outlook for 2027 is broadly positive, supported by a Buy consensus among 80% of covering analysts.
Frequently asked questions
EWTX forecast · 8 questionsAccording to 10 Wall Street analysts, the average 12-month EWTX price target is $47.57, with a high forecast of $66.00 and a low of $25.00. The median price target is shown in the chart above when available. This implies +37.1% potential upside from the current price of $34.70.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.